Actavis has named new lawyers brought on its team as the pharmaceutical conglomerate readies to appeal a court decision made only days ago barring the company from product-hopping.
Actavis has named Lisa Blatt of Arnold & Porter, along with George Conway III from Wachtell, Lipton, Rosen & Katz, to make the case for appealing US District Judge Robert Sweet’s December 11 ruling that bars the company from swapping out its Alzheimer’s treatment Namenda, whose patent is about to expire, for another version of the same drug with a patent valid for the next several years. Judge Sweet found that the tactic, known as product-hopping, was intended to thwart competition from generic drug makers.
But Actavis plans to appeal the decision to the US Court of Appeals for the Second Circuit, according to reports.
New York Attorney General Eric Schneiderman filed a lawsuit against Actavis and its Forest Laboratories on claims the Namenda product-hopping was anticompetitive and illegal.
Blatt and Conway III will join Actavis’s defense alongside representatives from White & Case.
Full content: Litigation Daily
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI